Veradermics, Incorporated
Status: Publicly traded
Direct answer
Veradermics, Incorporated is publicly traded on NYSE under the ticker MANE.
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss...
Can you invest in Veradermics, Incorporated?
Yes. Veradermics, Incorporated trades publicly on NYSE as MANE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Veradermics, Incorporated
Detailed equity research is provided by MarketSnap.